Vyome Holdings, Inc. (HIND) - Total Assets
Based on the latest financial reports, Vyome Holdings, Inc. (HIND) holds total assets worth $7.05 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See net assets of Vyome Holdings, Inc. for net asset value and shareholders' equity analysis.
Vyome Holdings, Inc. - Total Assets Trend (2003–2024)
This chart illustrates how Vyome Holdings, Inc.'s total assets have evolved over time, based on quarterly financial data.
Vyome Holdings, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Vyome Holdings, Inc.'s total assets of $7.05 Million consist of 95.7% current assets and 4.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 14.5% |
| Accounts Receivable | $1.03 Million | 21.5% |
| Inventory | $2.46 Million | 51.3% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Vyome Holdings, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Vyome Holdings, Inc. market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vyome Holdings, Inc.'s current assets represent 95.7% of total assets in 2024, an increase from 0.0% in 2003.
- Cash Position: Cash and equivalents constituted 14.5% of total assets in 2024, up from 0.0% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2003.
- Asset Diversification: The largest asset category is inventory at 51.3% of total assets.
Vyome Holdings, Inc. Competitors by Total Assets
Key competitors of Vyome Holdings, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fortress Biotech Inc
NASDAQ:FBIO
|
USA | $185.55 Million |
|
Summit Therapeutics PLC
NASDAQ:SMMT
|
USA | $261.73 Million |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Apellis Pharmaceuticals Inc
NASDAQ:APLS
|
USA | $1.08 Billion |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
|
China | CN¥16.55 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
BioArctic AB (publ)
ST:BIOA-B
|
Sweden | Skr2.60 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Vyome Holdings, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | 1.33 | 0.57 |
| Quick Ratio | 1.94 | 0.60 | 0.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $2.92 Million | $1.31 Million | $-6.12 Million |
Vyome Holdings, Inc. - Advanced Valuation Insights
This section examines the relationship between Vyome Holdings, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.38 |
| Latest Market Cap to Assets Ratio | 2.31 |
| Asset Growth Rate (YoY) | -55.3% |
| Total Assets | $4.79 Million |
| Market Capitalization | $11.06 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Vyome Holdings, Inc.'s assets at a significant premium (2.31x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Vyome Holdings, Inc.'s assets decreased by 55.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Vyome Holdings, Inc. (2003–2024)
The table below shows the annual total assets of Vyome Holdings, Inc. from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $4.79 Million | -55.32% |
| 2023-12-31 | $10.73 Million | -4.78% |
| 2022-12-31 | $11.27 Million | -78.56% |
| 2021-12-31 | $52.53 Million | +32.27% |
| 2020-12-31 | $39.71 Million | +0.15% |
| 2019-12-31 | $39.66 Million | -14.30% |
| 2018-12-31 | $46.27 Million | -47.84% |
| 2017-12-31 | $88.70 Million | +1159.84% |
| 2016-12-31 | $7.04 Million | -39.23% |
| 2015-12-31 | $11.59 Million | -19.46% |
| 2014-12-31 | $14.39 Million | -45.48% |
| 2013-12-31 | $26.39 Million | +1.12% |
| 2012-12-31 | $26.10 Million | -19.67% |
| 2011-12-31 | $32.49 Million | -16.03% |
| 2010-12-31 | $38.69 Million | +138.60% |
| 2009-12-31 | $16.21 Million | -42.66% |
| 2008-12-31 | $28.28 Million | -52.11% |
| 2007-12-31 | $59.05 Million | +63.74% |
| 2006-12-31 | $36.06 Million | +211.95% |
| 2005-12-31 | $11.56 Million | +1512.39% |
| 2003-12-31 | $717.00K | -- |
About Vyome Holdings, Inc.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.